Evaxion Biotech A/S held its Annual General Meeting on April 16, 2026, where shareholders approved the 2025 Annual Report and re-elected four board members while electing one new director.
Key takeaways
The 2025 Annual Report was approved by shareholders at the Annual General Meeting.
Four existing board members were re-elected: Marianne Søgaard, Lars Holtug, Lars Aage Staal Wegner, and Roberto Prego Pineda.
Jens Bitsch Nørhave was newly elected to the Board of Directors.
The meeting was held at the company's offices in Copenhagen, Denmark.